150 related articles for article (PubMed ID: 34449737)
1. The Effect of HBV/HCV in Response to HAART in HIV Patients after 12 Months in Kumba Health District in the South West Region of Cameroon.
Ndifontiayong AN; Ali IM; Sokoudjou JB; Ndimumeh JM; Tume CB
Trop Med Infect Dis; 2021 Aug; 6(3):. PubMed ID: 34449737
[TBL] [Abstract][Full Text] [Related]
2. The effect of highly active antiretroviral therapy on liver function in human immunodeficiency virus-infected pediatric patients with or without hepatitis virus co-infection.
Wu L; Jin C; Bai S; Davies H; Rao H; Liang Y; Wu N
J Res Med Sci; 2015 Feb; 20(2):127-32. PubMed ID: 25983763
[TBL] [Abstract][Full Text] [Related]
3. Rates and impact of hepatitis on human immunodeficiency virus infection in a large African cohort.
Ladep NG; Agaba PA; Agbaji O; Muazu A; Ugoagwu P; Imade G; Cooke G; McCormack S; Taylor-Robinson SD; Idoko J; Kanki P
World J Gastroenterol; 2013 Mar; 19(10):1602-10. PubMed ID: 23538773
[TBL] [Abstract][Full Text] [Related]
4. Kidney and liver organ transplantation in persons with human immunodeficiency virus: An Evidence-Based Analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(4):1-56. PubMed ID: 23074407
[TBL] [Abstract][Full Text] [Related]
5. HBV, HCV, and HBV/HCV co-infection among HIV-positive patients in Hunan province, China: Regimen selection, hepatotoxicity, and antiretroviral therapy outcome.
Su S; Fairley CK; Sasadeusz J; He J; Wei X; Zeng H; Jing J; Mao L; Chen X; Zhang L
J Med Virol; 2018 Mar; 90(3):518-525. PubMed ID: 29091279
[TBL] [Abstract][Full Text] [Related]
6. Hepatotoxicity and effectiveness of a Nevirapine-based antiretroviral therapy in HIV-infected patients with or without viral hepatitis B or C infection in Cameroon.
Mbougua JB; Laurent C; Kouanfack C; Bourgeois A; Ciaffi L; Calmy A; Gwet H; Koulla-Shiro S; Ducos J; Mpoudi-Ngolé E; Molinari N; Delaporte E
BMC Public Health; 2010 Mar; 10():105. PubMed ID: 20193053
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Demographic, Epidemiological, Immunological, and Clinical Characteristics of Patients with HIV Mono-infection Versus Patients Co-infected with HCV or/and HBV: A Serbian Cohort Study.
Ranin J; Salemovic D; Brmbolic B; Marinkovic J; Boricic I; Pesic PI; Zerjav S; Stanojevic M; Jevtovic D
Curr HIV Res; 2018; 16(3):222-230. PubMed ID: 30014804
[TBL] [Abstract][Full Text] [Related]
8. Assessing the association between platelets and immune recovery in HIV/HBV co-infected patients: A long-term cohort in Asia.
Nie Y; Lan Y; Deng XZ; Li LH; Cai WP; Li F; Hu FY
Infect Genet Evol; 2020 Oct; 84():104480. PubMed ID: 32736042
[TBL] [Abstract][Full Text] [Related]
9. Seroprevalence and effect of HBV and HCV co-infections on the immuno-virologic responses of adult HIV-infected persons on anti-retroviral therapy.
Annison L; Hackman H; Eshun PF; Annison S; Forson P; Antwi-Baffour S
PLoS One; 2022; 17(11):e0278037. PubMed ID: 36417469
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B and C Co-Infection in HIV Patients from the TREAT Asia HIV Observational Database: Analysis of Risk Factors and Survival.
Chen M; Wong WW; Law MG; Kiertiburanakul S; Yunihastuti E; Merati TP; Lim PL; Chaiwarith R; Phanuphak P; Lee MP; Kumarasamy N; Saphonn V; Ditangco R; Sim BL; Nguyen KV; Pujari S; Kamarulzaman A; Zhang F; Pham TT; Choi JY; Oka S; Kantipong P; Mustafa M; Ratanasuwan W; Durier N; Chen YM
PLoS One; 2016; 11(3):e0150512. PubMed ID: 26933963
[TBL] [Abstract][Full Text] [Related]
11. Sero-prevalence of Hepatitis B and C viral co-infections among HIV-1 infected ART-naïve individuals in Kumasi, Ghana.
Boateng R; Mutocheluh M; Dompreh A; Obiri-Yeboah D; Odame Anto E; Owusu M; Narkwa PW
PLoS One; 2019; 14(4):e0215377. PubMed ID: 31002687
[TBL] [Abstract][Full Text] [Related]
12. HIV/HBV and HIV/HCV coinfection, and outcomes following highly active antiretroviral therapy.
Lincoln D; Petoumenos K; Dore GJ;
HIV Med; 2003 Jul; 4(3):241-9. PubMed ID: 12859323
[TBL] [Abstract][Full Text] [Related]
13. Impact of hepatitis B virus infection on HIV response to antiretroviral therapy in a Chinese antiretroviral therapy center.
Yang R; Gui X; Xiong Y; Gao SC; Yan Y
Int J Infect Dis; 2014 Nov; 28():29-34. PubMed ID: 25236390
[TBL] [Abstract][Full Text] [Related]
14. Impact of hepatitis C virus co-infection on HIV patients before and after highly active antiretroviral therapy: an immunological and clinical chemistry observation, Addis Ababa, Ethiopia.
Taye S; Lakew M
BMC Immunol; 2013 May; 14():23. PubMed ID: 23679118
[TBL] [Abstract][Full Text] [Related]
15. Impact of viral hepatitis co-infection on response to antiretroviral therapy and HIV disease progression in the HIV-NAT cohort.
Law WP; Duncombe CJ; Mahanontharit A; Boyd MA; Ruxrungtham K; Lange JM; Phanuphak P; Cooper DA; Dore GJ
AIDS; 2004 May; 18(8):1169-77. PubMed ID: 15166532
[TBL] [Abstract][Full Text] [Related]
16. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.
Verweel G; van Rossum AM; Hartwig NG; Wolfs TF; Scherpbier HJ; de Groot R
Pediatrics; 2002 Feb; 109(2):E25. PubMed ID: 11826235
[TBL] [Abstract][Full Text] [Related]
17. Liver Function Tests Abnormalities and Hepatitis B Virus & Hepatitis C Virus Co-infection in Human Immunodeficiency Virus (HIV)-infected Patients in India.
Puri P; Sharma PK; Lolusare A; Sashindran VK; Shrivastava S; Nagpal AK
J Clin Exp Hepatol; 2017 Mar; 7(1):1-8. PubMed ID: 28348464
[TBL] [Abstract][Full Text] [Related]
18. Influence of hepatitis B virus co-infection on virological and immunological response to antiretroviral treatment among HIV patients attending comprehensive care clinics in Makueni County, Kenya.
Maitha GM; Kikuvi G; Wanzala P; Kirui F
Pan Afr Med J; 2021; 38():103. PubMed ID: 33889269
[TBL] [Abstract][Full Text] [Related]
19. Impact of chronic hepatitis C infection on outcomes of patients with an advanced stage of HIV-1 infection in an area of low prevalence of co-infection.
Hung CC; Chen MY; Hsieh SM; Hsiao CF; Sheng WH; Chang SC
Int J STD AIDS; 2005 Jan; 16(1):42-8. PubMed ID: 15705272
[TBL] [Abstract][Full Text] [Related]
20. HBV and HCV seroprevalence and their correlation with CD4 cells and liver enzymes among HIV positive individuals at University of Gondar Teaching Hospital, Northwest Ethiopia.
Wondimeneh Y; Alem M; Asfaw F; Belyhun Y
Virol J; 2013 May; 10():171. PubMed ID: 23721493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
